Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism PKG activators(protein kinase cGMP-dependent 1 activators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC27H26Cl2N2O6 |
InChIKeyREDPQDQMPNUDEP-NXCFDTQHSA-N |
CAS Registry2773367-58-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiovascular Diseases | Preclinical | US | 26 Aug 2022 |